Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial

London School of Hygiene & Tropical Medicine · Awarded

Buyer
London School of Hygiene & Tropical Medicine
Status
Awarded
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-02f911
Published
2023-08-21
Deadline
2026-04-19

Tender summary

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap